Cryogenic
Published over 2 years ago. See the latest and most current information on Cryogenic.
Lyobeads, aka lyophilised spheres, have become a popular technology in the field of freeze drying to the diagnostics industry, as the primary advantage is their flexibility in formulation. They allow for the development of a single formulation that can be easily adjusted for various applications, even in different container types. This versatility can significantly reduce research and development (R&D) investment, making lyobeads an attractive option for diagnostic companies.
Biopharma Group has been at the forefront of lyobead processing evolution, supporting many customers to increase productivity whilst achieving significant cost and time savings.
To further enhance these benefits, from late 2023, the new LyobeadPRO™, designed and developed by Biopharma Group's technical specialists, will be available to provide a device to produce the highest quality lyobeads with precise volume and shape.
The LyobeadPRO™, is a lyobead generator specifically designed to meet the need for dosing material that is measured by finely adjustable controls to ensure repeatability from bead to bead, with droplets dispensed into a controlled segmented rotating dewar of liquid nitrogen to ensure snap freezing is achieved, avoiding bead aggregation (clumping).
Why Choose the LyobeadPRO™?
Dispensing accuracy in diagnostic tests, for example, is crucial not only for technical accuracy but also for ensuring patient safety, meeting regulatory standards, and optimising resource usage – key factors for effective and reliable diagnostics.
By utilising the LyobeadPRO™ in your lyobead processing, you gain from the following:
In summary, the LyobeadPRO™ device is a versatile and user-friendly tool that offers precise control over lyobead production, making it well-suited for industries where the quality, consistency, and accuracy is essential.
More information online
ILM Guide 2026/27